Compass Therapeutics, Inc.

CMPX · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$43,483$24,228$34,946$144,514
Short-Term Investments$83,239$128,233$151,663$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$6,029$1,420$8,182$2,591
Total Curr. Assets$132,751$153,881$194,791$147,105
Property Plant & Equip (Net)$7,084$2,674$4,534$6,332
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$568$320$320$320
Total NC Assets$7,652$2,994$4,854$6,652
Other Assets$0$0$0$0
Total Assets$140,403$156,875$199,645$153,757
Liabilities
Payables$2,249$4,090$3,382$867
Short-Term Debt$338$1,197$1,097$989
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$6,287$2,514$11,690$8,775
Total Curr. Liab.$8,874$7,801$16,169$10,631
LT Debt$6,296$536$1,838$3,048
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$1$0$0$0
Total NC Liab.$6,297$536$1,838$3,048
Other Liabilities$0$0$0$0
Cap. Leases$6,634$1,733$2,935$4,037
Total Liabilities$15,171$8,337$18,007$13,679
Equity
Pref Stock$0$0$0$0
Common Stock$13$13$13$10
Retained Earnings-$364,683-$315,308-$272,814-$233,589
AOCI$210$37-$302$0
Other Equity$489,692$463,796$454,741$373,657
Total Equity$125,232$148,538$181,638$140,078
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$140,403$156,875$199,645$153,757
Net Debt-$36,849-$22,495-$32,011-$140,477